The Stroke Service at Hamad Medical Corporation (HMC) has recently successfully achieved Joint Commission International (JCI) re-accreditation as the primary stroke center across the whole spectrum of the service.

This reaccreditation is also important as it was the first of its kind to be done virtually at HMC during the Covid-19 pandemic. The Stroke Service at HMC was first accredited by Joint Commission International in November 2014 as the first ever Primary Stroke Centre within the Middle East and the service was reaccredited in 2018.

Dr. Ahmed Own, Acting Director of HMC’s Neurosciences Institute, pointed to the recent development of work teams in stroke care services, specifically during the COVID-19 pandemic, noting that these services achieved significant improvements during the past decade, in terms of the way patients are provided with care. Dr. Ahmed said that last year 2,500 patients were admitted to the hospital, of whom more than 1,500 were confirmed to have had a stroke.

Source: Government of Qatar